BTIG Reiterates Buy Rating on DexCom (DXCM)

Go back to BTIG Reiterates Buy Rating on DexCom (DXCM)

Dexcom Reports Third Quarter 2024 Financial Results

October 24, 2024 4:03 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2024.

Third Quarter 2024 Financial Highlights:

Revenue grew 2% year-over-year to $994.2 million on a reported basis and 3% year-over-year on an organic1 basis. U.S. revenue declined 2% and... More